Livalo is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Kowa Pharmaceuticals America, Inc.. The primary component is Pitavastatin Calcium.
| Product ID | 66869-204_1783ecd3-0116-4ad8-9a43-25d5b2dc62e6 |
| NDC | 66869-204 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Livalo |
| Generic Name | Pitavastatin Calcium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-05-16 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022363 |
| Labeler Name | Kowa Pharmaceuticals America, Inc. |
| Substance Name | PITAVASTATIN CALCIUM |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2019-05-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022363 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-16 |
| Marketing Category | NDA |
| Application Number | NDA022363 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-05-16 |
| Ingredient | Strength |
|---|---|
| PITAVASTATIN CALCIUM | 2.09 mg/1 |
| SPL SET ID: | 44dcbf97-99ec-427c-ba50-207e0069d6d2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66869-104 | Livalo | pitavastatin calcium |
| 66869-204 | Livalo | pitavastatin calcium |
| 66869-404 | Livalo | pitavastatin calcium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LIVALO 79016899 3228048 Live/Registered |
KOWA COMPANY, LTD. 2005-08-26 |
![]() LIVALO 76600233 2993941 Dead/Cancelled |
Livalo Design Inc. 2004-07-01 |
![]() LIVALO 76147782 not registered Dead/Abandoned |
Livalo Design Inc. 2000-10-16 |